SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 31.10 |
Enterprise Value ($M) | 21.09 |
Book Value ($M) | 7.44 |
Book Value / Share | 4.17 |
Price / Book | 4.18 |
NCAV ($M) | 7.43 |
NCAV / Share | 4.17 |
Price / NCAV | 4.19 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.43 |
Return on Assets (ROA) | -1.25 |
Return on Equity (ROE) | -1.38 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.77 |
Current Ratio | 3.77 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 10.11 |
Assets | 10.12 |
Liabilities | 2.68 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -10.96 |
Net Income | -10.65 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -7.36 |
Cash from Investing | -0.01 |
Cash from Financing | 8.98 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Havlickova 648 a.s. | 4.39 | 18.03 | |
13D | Pham Quang X | 23.60 | -93.34 | |
13G/A | Murphy John Raymond | 2.96 | -92.56 | |
13G/A | Armistice Capital, Llc | 4.99 | -94.38 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
10,253 | 44,200 | 23.20 | |
5,649 | 26,339 | 21.45 | |
10,445 | 55,683 | 18.76 | |
12,722 | 44,025 | 28.90 | |
13,953 | 42,463 | 32.86 | |
(click for more detail) |
Similar Companies | |
---|---|
CSCI – COSCIENS Biopharma Inc. | CTXR – Citius Pharmaceuticals, Inc. |
CUE – Cue Biopharma, Inc. | CYCC – Cyclacel Pharmaceuticals, Inc. |
CYCN – Cyclerion Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io